Where are we moving in the classification of idiopathic infl... : Current Opinion in Neurology
Where are we moving in the classification of idiopathic inflammatory myopathies? : Current …

Anti-synthetase syndrome (ASSD) is an autoimmune disease characterized by the presence
of autoantibodies targeting one of several aminoacyl t-RNA synthetases (aaRSs) along with …

Idiopathic inflammatory myopathies are a group of rare, immune-mediated diseases that
primarily affect the skeletal muscle but can also involve other organs such as the lungs, skin …

The aim of the study was to summarize current knowledge on antisynthetase syndrome
(ASS), including its epidemiology, pathogenesis, proposed so far diagnostic criteria …

Antisynthetase syndrome (ASyS) is an autoimmune disease clinically manifested most often
by interstitial lung disease, myositis, and arthritis. Raynaud's syndrome, fever, and rashes …

Systemic sclerosis and autoimmune myositis are both associated with decreased quality of
life and increased mortality. Their prognosis and management largely depend on the …

Interstitial lung disease (ILD) has been recognized as a frequent manifestation associated
with a substantial morbidity and mortality burden in patients with autoimmune rheumatic …

Background Interstitial lung disease (ILD) is frequently observed in anti-melanoma
differentiation-associated protein 5 (MDA5) antibody positive dermatomyositis (DM) and anti …

Interstitial lung disease is a common pulmonary manifestation of connective tissue diseases
and results in significant morbidity and mortality. Although all connective tissue diseases are …

The past decade has seen tremendous development in digital health, including in innovative
new technologies such as Electronic Health Records, telemedicine, virtual visits, wearable …